Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-22
1995-04-18
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 546 16, 544 6, 544 70, C07D40104, A61K 3147
Patent
active
054079438
CLAIM:
1. A compound of the formula ##STR16## wherein R.sup.1 is hydrogen, C.sub.1 -C.sub.3 alkyl, benzyl, or a pharmaceutically acceptable cation,
A is CH, CF CCl, COCH.sub.3, C-CH.dbd.CH.sub.2, C--(C.sub.1 -C.sub.3) alkyl, C--CF.sub.3, C--CN or N;
Y is C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.2 haloalkyl, cyclopropyl, halocyclopropyl, vinyl, 4-halophenyl, 2,4-difluorophenyl, methoxy or NHCH.sub.3 ; ##STR17## R.sup.2 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, amino, halogen or aminomethyl; and
R.sup.3 is a group of the formula ##STR18## wherein R.sup.5 is hydrogen or C.sub.1 -C.sub.3 alkyl, R.sup.6 and R.sup.7 are each independently hydrogen, C.sub.1 -C.sub.3 alkyl or halogen, m is 2 or 3, p is 1 or 2, q is 2 or 3 p+q is 4, and R.sup.6 is located next to the group NHR.sup.5.
2. A compound according to claim 1 wherein R.sup.1 is hydrogen and A is CH or N.
3. A compound according to claim 1 wherein Y is cyclopropyl or 2,4-difluorophenyl.
4. A compound according to claim 1 wherein said compound is 7-(1-amino-6-azaspiro[2.5]oct-6-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-di hydro-4-oxo-naphthyridine-3-carboxylic acid, 7-(1-amino-6-azaspiro[2.5]oct-6-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-o xo-quinoline-3-carboxylic acid, 7-(1-amino-6-azaspiro[2.5]oct-6-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-o xo-1,8-naphthyridine-3-carboxylic acid, 7-(trans-1-amino-5-azaspiro[2.5]oct-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihyd ro-4-oxo-1,8-naphthyridine-3-carboxylic acid, or 7-(2-amino-7-azaspiro[3.5]non-7-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-di hydro-4-oxo-1,8-naphthyridine-3-carboxylic acid.
5. A compound according to claim 1, wherein R.sup.3 is 1-amino-6-azaspiro[2.5]oct-6-yl.
6. A compound according to claim 1, wherein R.sup.3 is 1-amino-5-azaspiro[2.5]oct-5-yl.
7. A compound according to claim 1, wherein R.sup.3 is 2-amino-7-azaspiro[3.5]non-7-yl.
8. An antibacteral composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.
9. A method of treating a host afffected by a bacterial infection which comprises administering to said host an antibacterially effective amount of a compound according to claim 1.
REFERENCES:
patent: 4571396 (1986-02-01), Hutt et al.
patent: 5245037 (1993-09-01), Kuramoto
Berch Mark L.
Ginsburg Paul H.
Holtrust Gezina
Pfizer Inc.
Richardson Peter C.
LandOfFree
Azaspiro quinolone antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaspiro quinolone antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaspiro quinolone antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-67506